Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06OFY
|
|||
Former ID |
DNC009116
|
|||
Drug Name |
[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid
|
|||
Synonyms |
CHEMBL478147; [4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid; SCHEMBL12932182; BDBM50267207
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H24N2O3
|
|||
Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=C(C=C4)CC(=O)O
|
|||
InChI |
1S/C19H24N2O3/c22-17(23)8-12-1-3-16(4-2-12)20-18(24)21-19-9-13-5-14(10-19)7-15(6-13)11-19/h1-4,13-15H,5-11H2,(H,22,23)(H2,20,21,24)
|
|||
InChIKey |
QDEKKGRIPYLLDK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.